27 results on '"Dupre, Pierre-Francois"'
Search Results
2. Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery
3. Family history of postpartum hemorrhage is a risk factor for postpartum hemorrhage after vaginal delivery: results from the French prospective multicenter Haemorrhages and Thromboembolic Venous Disease of the Postpartum cohort study
4. Endometrial cancer of the very elderly: Management and survival in the Francogyn population
5. Clinical risk factors for vasculo-placental disorders: results from a prospective case-control study nested in HEMOTHEPP French cohort study
6. Omission of lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy: The CARACO phase III randomized trial.
7. Impact of severe obesity in the management of patients with high-risk endometrial cancer: A FRANCOGYN study
8. Long-term outcomes in patients with PET-predicted poor-responsive HER2-positive breast cancer treated with neoadjuvant bevacizumab added to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study
9. Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT)
10. CHRONO: randomized trial of the CHROnology of surgery after Neoadjuvant chemotherapy for Ovarian cancer
11. Implementing a comprehensive cervical cancer program in Southern Malawi: a ‘Médecins Sans Frontières’, Ministry of Health, and College of Medicine of Blantyre Collaborative Project
12. Adherence to ESGO guidelines and impact on survival in obese patients with endometrial cancer: a multicentric retrospective study
13. Use of [18F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [18F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial
14. Validation of the French translation of a self-administered questionnaire looking for a history of pre-eclampsia
15. Effect of high-dose chemotherapy with autologous stem cell rescue (HDC-aSCR) on outcome in ovarian small-cell carcinoma, hypercalcemic type (SCCOHT): Prospective series from the French Rare Gynecologic Malignant Tumors Network (TMRG).
16. Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS study
17. Vulvar squamous cell carcinoma complicating hidradenitis suppurativa in a young woman
18. Chapitre 25 - Surveillance post-thérapeutique et prise en charge des séquelles dans le cadre des cancers gynécologiques pelviens
19. Microstrip back-cavity Hilbert Fractal Antenna for experimental detection of breast tumors
20. Abstract P2-01-01: Sentinel node surgery after neoadjuvant chemotherapy in patient with axillary node involvement: The French GANEA 2 prospective multi-institutional trial
21. Monte-Carlo dosimetry for intraoperative radiotherapy using a low energy x-ray source
22. Fibromatose mammaire chez une fillette de neuf ans
23. Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: Results of the CAVECCAS study.
24. AVATAXHER: An open-label, randomized, multicenter study investigating the addition of bevacizumab (B) to neoadjuvant trastuzumab (T) plus docetaxel (D) in patients with early stage HER2-positive breast cancer (HER2+ BC) stratified according to PET change after one therapy cycle.
25. Incidence and Risk Factors for Central Venous Catheter-Related Venous Thromboembolism in Breast Cancer Patients Under Neoadjuvant Chemotherapy: the Caveccas (Catheter Veineux Central et Cancer du Sein) Study
26. An open-label randomized, multicenter, phase II study on neoadjuvant treatment with trastuzumab plus docetaxel versus trastuzumab plus docetaxel plus bevacizumab according to positron emission tomography (PET) value modification in patients with early stage HER2-positive breast cancer (AVATAXHER): Design description.
27. Auteurs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.